Augmented reality is no longer a novelty

GUEST: Analysts project mobile augmented reality to become the primary driver of the global AR and VR market. In 2017 Digi-Capital projected the AR market got even stronger than expected. AR is one of the hottest technology developments in the mobile industry, but it’s is still far from being a major platform. Ultimately, AR has five[…]

Bill Introduced to Make South Korean Officials Declare Their Crypto Investments

A bill has been introduced in South Korea to require public officials to declare their investments in cryptocurrencies including bitcoin. This initiative follows the recent controversies within the government regarding cryptocurrency regulations, including insider trading and market manipulation. Also read: South Korea Urges 23 Countries, EU, and IMF to Collaborate on Curbing Crypto Trading Bills for[…]

Women in Cloud Summit unveils new initiatives to seize ‘the biggest opportunities of our lives’

Gavriella Schuster, Microsoft corporate vice president for commercial partner channels and programs, left, with Carrie Francey, Hewlett Packard Enterprise vice president strategic alliances, at the inaugural Women in Cloud Summit in Redmond. (Tony Lystra Photo) Microsoft and Hewlett Packard Enterprise are launching a new six-month Cloud Accelerator Lab to help women start businesses in the cloud[…]

The Satoshi Revolution – Chapter 4: Is Privacy Possible in the Digital Era? (Part 3)

The Satoshi Revolution: A Revolution of Rising Expectations. Section 2 : The Moral Imperative of Privacy Chapter 4: When Privacy is Criminalized, Only Criminals will be Private by Wendy McElroy Is Privacy Possible in the Digital Era? (Chapter 4, Part 3) Recent inventions and business methods call attention to the next step which must be[…]

New 'Reactionware' 3D Printing System Spits Out Pharmaceuticals On-Demand

The pharmaceutical industry is the very definition of a centralization. It is, after all, an industry predicated on carefully litigated intellectual property, intense de facto regulatory and legal scrutiny, and large-scale, capital-intensive chemical manufacturing infrastructure. As such, it’s slow-moving. Drug distribution is thus anticipatory rather than responsive. This tends to work out at large (epidemiological)[…]